JPS5747915B2 - - Google Patents

Info

Publication number
JPS5747915B2
JPS5747915B2 JP49043725A JP4372574A JPS5747915B2 JP S5747915 B2 JPS5747915 B2 JP S5747915B2 JP 49043725 A JP49043725 A JP 49043725A JP 4372574 A JP4372574 A JP 4372574A JP S5747915 B2 JPS5747915 B2 JP S5747915B2
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP49043725A
Other languages
Japanese (ja)
Other versions
JPS50140492A (en
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to JP49043725A priority Critical patent/JPS5747915B2/ja
Priority to GB15001/75A priority patent/GB1497827A/en
Priority to DE19752516674 priority patent/DE2516674A1/en
Priority to FR7512027A priority patent/FR2267786B1/fr
Publication of JPS50140492A publication Critical patent/JPS50140492A/ja
Publication of JPS5747915B2 publication Critical patent/JPS5747915B2/ja
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/44—Radicals substituted by doubly-bound oxygen, sulfur, or nitrogen atoms, or by two such atoms singly-bound to the same carbon atom
    • C07D213/46—Oxygen atoms
    • C07D213/50—Ketonic radicals
JP49043725A 1974-04-17 1974-04-17 Expired JPS5747915B2 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
JP49043725A JPS5747915B2 (en) 1974-04-17 1974-04-17
GB15001/75A GB1497827A (en) 1974-04-17 1975-04-11 Triazolobenzodiazepine derivatives
DE19752516674 DE2516674A1 (en) 1974-04-17 1975-04-16 HETEROCYCLIC COMPOUNDS, METHOD FOR PREPARING THE SAME AND PHARMACEUTICAL PRODUCTS CONTAINING THEM
FR7512027A FR2267786B1 (en) 1974-04-17 1975-04-17

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP49043725A JPS5747915B2 (en) 1974-04-17 1974-04-17

Publications (2)

Publication Number Publication Date
JPS50140492A JPS50140492A (en) 1975-11-11
JPS5747915B2 true JPS5747915B2 (en) 1982-10-13

Family

ID=12671752

Family Applications (1)

Application Number Title Priority Date Filing Date
JP49043725A Expired JPS5747915B2 (en) 1974-04-17 1974-04-17

Country Status (4)

Country Link
JP (1) JPS5747915B2 (en)
DE (1) DE2516674A1 (en)
FR (1) FR2267786B1 (en)
GB (1) GB1497827A (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4299126A3 (en) * 2014-06-26 2024-04-03 The Johns Hopkins University Peripherally restricted gaba positive allosteric modulators for the treatment of irritable bowel syndrome and other ailments of the peripheral nervous system

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE758921A (en) * 1969-11-15 1971-04-16 Takeda Chemical Industries Ltd BENZODIAZEPINE DERIVATIVES
DE2159527A1 (en) * 1970-12-11 1972-06-22 Ciba-Geigy Ag, Basel (Schweiz) Process for the preparation of diazepine derivatives and new diazepine derivatives which can be prepared by these processes
CH562246A5 (en) * 1971-04-08 1975-05-30 Ciba Geigy Ag
BE786530A (en) * 1971-07-23 1973-01-22 Ciba Geigy PROCESS FOR PREPARATION OF NEW DIAZEPINE DERIVATIVES AND COMPOUNDS OBTAINED
BE786529A (en) * 1971-07-23 1973-01-22 Ciba Geigy NEW DIAZEPINE DERIVATIVES AND METHODS FOR THEIR PREPARATION
BE795020A (en) * 1972-02-07 1973-08-06 Ciba Geigy PROCESS FOR PREPARING NEW DIAZEPINES

Also Published As

Publication number Publication date
DE2516674A1 (en) 1975-10-30
JPS50140492A (en) 1975-11-11
FR2267786A1 (en) 1975-11-14
FR2267786B1 (en) 1978-07-28
GB1497827A (en) 1978-01-12

Similar Documents

Publication Publication Date Title
FR2257737B1 (en)
JPS50125002A (en)
FR2269569B3 (en)
JPS50126971A (en)
FR2267786B1 (en)
JPS50134438A (en)
JPS50110106A (en)
JPS50111988U (en)
JPS50152889U (en)
JPS50147883U (en)
CS169549B1 (en)
JPS5119582U (en)
JPS50116333U (en)
JPS50160760A (en)
JPS50119356A (en)
JPS50121676A (en)
JPS50129088A (en)
AU7478474A (en)
JPS50139313U (en)
JPS50153418U (en)
JPS50142243U (en)
AR198461Q (en)
CH571909A5 (en)
CH577228A5 (en)
AU479408A (en)